Company: WELNF
Filing Date: 2025-10-31
Form Type: PRE 14A
Source: 0001104659-25-104954
Chunk: 4

Company: Integrated Wellness Acquisition Corp
Filing Date: 2025-10-31
Form: PRE 14A
Chunk 4
---
the “December 2024 Extension”).

As a result of the June 2023
Extension, the December 2023 Extension and the December 2024 Extension, and as provided in the M&A, the Company currently
has until December 15, 2025 to complete its Business Combination. While the Company is using its best efforts to complete the Business
Combination as soon as practicable, the board of directors (the “Board”) believes that there may not be sufficient
time before the Termination Date to complete the Business Combination. Accordingly, the Board believes that in order to be able to consummate
the Business Combination, the Company will need to obtain approval for the Extension. Without the Extension, the Board believes that there
is significant risk that the Company might not, despite its best efforts, be able to complete the Business Combination on or before the
Termination Date. If that were to occur, the Company would be precluded from completing the Btab Business Combination or another Business
Combination and would be forced to liquidate even if the Company’s shareholders are otherwise in favor of consummating such transaction.

Therefore, the Board has
determined that it is in the best interests of the Company’s shareholders to extend the date by which the Company has to consummate
the Business Combination to the Extended Date in order that the Company’s shareholders have the opportunity to participate in its
future investment, as well as to provide additional flexibility to wind up our operations prior to the end of the Extension Period.

<div align='center'>3</div>

If the M&A Amendment
Proposals are approved and implemented, the Company intends to complete the Business Combination as soon as possible and in any event
on or before the Extended Date. The Board will have the discretion to liquidate the Trust Account to redeem all public shares on a specified
date following the adoption of the M&A Amendments at any time before or after the current Termination Date, and prior to the end of
the Extension Period. Notwithstanding shareholder approval of the M&A Amendments, our Board will retain the right to abandon and not
implement the M&A Amendments at any time before the implementation thereof without any further action by our shareholders.

You are not being asked to vote on the Business Combination at the Meeting. The vote by the Company shareholders on the Business Combination will occur at the separate Business Combination Meeting (as defined below) of the Company shareholders and the solicitation of proxies from the Company shareholders in connection with such separate Business Combination Meeting, and